Danske Bank’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$35M Sell
819,227
-15,520
-2% -$843K 0.07% 219
2026
Q1
$52.4M Sell
834,747
-30,315
-4% -$2.43M 0.13% 146
2025
Q4
$82.5M Sell
865,062
-103,023
-11% -$10.1M 0.19% 97
2025
Q3
$94.5M Sell
968,085
-119,385
-11% -$12.4M 0.24% 75
2025
Q2
$117M Buy
1,087,470
+191,027
+21% +$19.3M 0.29% 63
2025
Q1
$90.4M Buy
896,443
+165,101
+23% +$16.6M 0.28% 65
2024
Q4
$65.3M Buy
731,342
+106,058
+17% +$9.34M 0.2% 88
2024
Q3
$52.4M Buy
625,284
+15,900
+3% +$1.25M 0.17% 104
2024
Q2
$46.9M Sell
609,384
-154,370
-20% -$11.3M 0.17% 107
2024
Q1
$52.3M Buy
+763,754
New +$49.1M 0.16% 119

Other funds holding BSX

Danske Bank's BSX Position: Q2 2026 in Review

Danske Bank reduced its Boston Scientific (BSX) stake by 1.9% in Q2 2026, selling an estimated $843K and leaving 819,227 shares worth $35M. The position accounts for 0.07% of the portfolio, ranked #219.

Danske Bank first reported a position in BSX in Q1 2024 and has held it in 10 quarters since. The position peaked at $117M in Q2 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Danske Bank held 819,227 shares of Boston Scientific worth $35M as of Q2 2026.
  • Danske Bank sold 15,520 Boston Scientific shares in Q2 2026, an estimated $843K.
  • Boston Scientific made up 0.07% of Danske Bank's portfolio in Q2 2026, its #219 holding.
  • Danske Bank first reported a position in Boston Scientific in Q1 2024 and has held it in 10 quarters since.
  • Danske Bank's Boston Scientific position peaked at $117M in Q2 2025.
  • 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Danske Bank's 13F filing for Q2 2026, filed 10 Aug 2026.